{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:11Z","timestamp":1790164931566,"version":"4.1.0"},"reference-count":167,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Atypical depression was first described in the 1950s, but after a surge of interest and publications in the 1980s, this construct appears to have fallen out of focus, with comparatively less literature produced over recent decades. Despite different conceptualisations proposed by different authors, atypical depression is considered by current nosographic classification systems to be characterised by mood reactivity, reversed neurovegetative symptoms such as hyperphagia or hypersomnia, marked fatigue and rejection sensitivity. Core features described in historical accounts also include prominent anxiety symptoms, reversed diurnal variation of mood, and a specific response to monoamine oxidase inhibitors (MAOIs). Many authors have reported latent or future bipolarity in subjects presenting with this depressive subtype, while others have explored a broader spectrum encompassing bipolar spectrum conditions and certain presentations of borderline personality disorder. From a pathophysiological perspective, current evidence suggests that atypical depression represents a biologically and clinically meaningful depressive phenotype, characterised by converging neuroendocrine, immuno-inflammatory, and metabolic alterations, including specific hypothalamic\u2013pituitary\u2013adrenal axis dysregulation and associations with obesity and type 2 diabetes. Additionally, the frequent overlap with the bipolar spectrum has implications for diagnostic formulation and treatment planning in at least a subset of patients. Notably, alongside the classically identified efficacy of MAOIs, a wide range of treatments appears also to be effective in the management of atypical depression, and emerging options like GLP-1 receptor agonists may theoretically prove preferentially efficacious in this depressive subtype.<\/jats:p>","DOI":"10.3389\/fpsyt.2026.1928447","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:19:18Z","timestamp":1790162358000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Atypical depression: state of the art and future perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Gianmarco","family":"Ingrosso","sequence":"first","affiliation":[{"name":"Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London","place":["London, United Kingdom"]},{"name":"The National Affective Disorders Service, South London and the Maudsley NHS Foundation Trust","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Cleare","sequence":"additional","affiliation":[{"name":"Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London","place":["London, United Kingdom"]},{"name":"The National Affective Disorders Service, South London and the Maudsley NHS Foundation Trust","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5136.1491","article-title":"Effects of iproniazid in depressive syndromes","volume":"1","author":"West","year":"1959","journal-title":"Br Med J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7326\/0003-4819-40-5-881","article-title":"The clinical effect of isoniazid and iproniazid in the treatment of pulmonary tuberculosis","volume":"40","author":"Bloch","year":"1954","journal-title":"Ann Intern Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bmj.1.5270.6","article-title":"Treatment of anxiety states by antidepressant drugs","volume":"1","author":"Sargant","year":"1962","journal-title":"Br Med J"},{"key":"B8","volume-title":"Diagnosis and Drug Treatment of Psychiatric Disorders","author":"Klein","year":"1969"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770290111010","article-title":"Clinical pharmacology of phenelzine","volume":"35","author":"Robinson","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.119.549.143","article-title":"Anxiety state or masked depression?: A study based on the action of monoamine oxidase inhibitors","volume":"119","author":"Pollitt","year":"1971","journal-title":"Br J Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.9.1470","article-title":"Atypical depression: a reappraisal","volume":"159","author":"Parker","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290050015005","article-title":"Atypical depression","volume":"39","author":"Davidson","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.128.10.1303","article-title":"Hypersomnia and manic-depressive disease","volume":"128","author":"Detre","year":"1972","journal-title":"Am J Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198210000-00007","article-title":"A double-blind study of tranylcypromine treatment of major anergic depression","volume":"170","author":"Himmelhoch","year":"1982","journal-title":"J Nerv Ment Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.7.910","article-title":"Tranylcypromine versus imipramine in anergic bipolar depression","volume":"148","author":"Himmelhoch","year":"1991","journal-title":"Am J Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.2.195","article-title":"Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression","volume":"149","author":"Thase","year":"1992","journal-title":"Am J Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790180039005","article-title":"Phenelzine v imipramine in atypical depression. A preliminary report","volume":"41","author":"Liebowitz","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"B18","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Ed","year":"1994"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000292465","article-title":"Columbia atypical depression: A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo","volume":"163","author":"Quitkin","year":"1993","journal-title":"Br J Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4088\/pcc.v04n0302","article-title":"Depression with atypical features: Diagnostic validity, prevalence, and treatment","volume":"4","author":"Quitkin","year":"2002","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"B21","first-page":"1050","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR","year":"2022"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(92)90043-6","article-title":"The validity of major depression with atypical features based on a community study","volume":"26","author":"Horwath","year":"1992","journal-title":"J Affect Disord"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830050025004","article-title":"The identification and validation of distinct depressive syndromes in a population-based sample of female twins","volume":"53","author":"Kendler","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.7.934","article-title":"Reversed neurovegetative symptoms of depression: a community study of Ontario","volume":"154","author":"Levitan","year":"1997","journal-title":"Am J Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1996.tb09884.x","article-title":"Atypical depressive symptoms and clusters in unipolar and bipolar depression","volume":"94","author":"Robertson","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.10.1398","article-title":"Latent class analysis of lifetime depressive symptoms in the national comorbidity survey","volume":"155","author":"Sullivan","year":"1998","journal-title":"Am J Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/depr.3050010506","article-title":"Atypical depression in an outpatient psychiatric population","volume":"1","author":"Zisook","year":"1993","journal-title":"Depression"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.8.817","article-title":"Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences","volume":"60","author":"Matza","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"B29","article-title":"Recognition and diagnosis of atypical depression","volume":"68","author":"Thase","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06227","article-title":"Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"73","author":"Blanco","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291797004765","article-title":"Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications","volume":"27","author":"Alpert","year":"1997","journal-title":"Psychol Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0165-1781(92)90067-d","article-title":"Secondary social phobia in patients with major depression","volume":"44","author":"Dilsaver","year":"1992","journal-title":"Psychiatry Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950150062011","article-title":"Generalized social phobia. Reliability and validity","volume":"52","author":"Mannuzza","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/archpsyc.49.4.290","article-title":"Phenelzine vs atenolol in social phobia. A placebo-controlled comparison","volume":"49","author":"Liebowitz","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2005.03.002","article-title":"Increased personality disorders and Axis I comorbidity in atypical depression","volume":"46","author":"McGinn","year":"2005","journal-title":"Compr Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2005.02.002","article-title":"A dimensional approach to personality in atypical depression","volume":"134","author":"Chopra","year":"2005","journal-title":"Psychiatry Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-11-120","article-title":"Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study","volume":"11","author":"Ross","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.10.025","article-title":"Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity","volume":"108","author":"Seem\u00fcller","year":"2008","journal-title":"J Affect Disord"},{"key":"B39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0010-440X(98)90080-3","article-title":"The high prevalence of \u201cSoft\u201d bipolar (II) features in atypical depression","volume":"39","author":"Perugi","year":"1998","journal-title":"Compr Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(02)00169-6","article-title":"Toward validation of atypical depression in the community: results of the Zurich cohort study","volume":"72","author":"Angst","year":"2002","journal-title":"J Affect Disord"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.12.038","article-title":"Bulimia nervosa in atypical depression: the mediating role of cyclothymic temperament","volume":"92","author":"Perugi","year":"2006","journal-title":"J Affect Disord"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.12.1746","article-title":"Major depression in individuals with a history of childhood physical or sexual abuse: relationship to neurovegetative features, mania, and gender","volume":"155","author":"Levitan","year":"1998","journal-title":"Am J Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1139\/jpn.0205","article-title":"Low-dose dexamethasone challenge in women with atypical major depression: pilot study","volume":"27","author":"Levitan","year":"2002","journal-title":"J Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.4088\/jcp.v66n0807","article-title":"Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D","volume":"66","author":"Novick","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"B45","first-page":"3","article-title":"The role of dopamine and norepinephrine in depression and antidepressant treatment","volume":"67","author":"Nutt","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"B46","article-title":"Monoamine oxidase inhibitors: from classic to new clinical approaches","volume-title":"Reactive Oxygen Species: Network Pharmacology and Therapeutic Applications","author":"Duarte","year":"2021"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328328d4d3","article-title":"Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression","volume":"19","author":"Aklillu","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1037\/\/0021-843x.98.2.177","article-title":"Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes","volume":"98","author":"Bruder","year":"1989","journal-title":"J Abnorm Psychol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.111.3.446","article-title":"Atypical depression: Enhanced right hemispheric dominance for perceiving emotional chimeric faces","volume":"111","author":"Bruder","year":"2002","journal-title":"J Abnorm Psychol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuroscience.2018.03.034","article-title":"The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder","volume":"403","author":"Woelfer","year":"2019","journal-title":"Neuroscience"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0177-4","article-title":"Imaging the neurobiological substrate of atypical depression by SPECT","volume":"34","author":"Pagani","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb44723.x","article-title":"Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs","volume":"771","author":"Gold","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0889-8529(01)00022-6","article-title":"Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications","volume":"31","author":"Gold","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2005.04.006","article-title":"A new view on hypocortisolism","volume":"30","author":"Fries","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.1.31","article-title":"Atypical depression: clinical aspects and noradrenergic function","volume":"152","author":"Asnis","year":"1995","journal-title":"Am J Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(96)02781-3","article-title":"Biological and clinical validation of atypical depression","volume":"60","author":"McGinn","year":"1996","journal-title":"Psychiatry Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000436","article-title":"Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features","volume":"4","author":"Anisman","year":"1999","journal-title":"Mol Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0555-4","article-title":"Different responses to dexamethasone and prednisolone in the same depressed patients","volume":"189","author":"Juruena","year":"2006","journal-title":"Psychopharmacol (Berl)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1525-1381.1999.09423.x","article-title":"The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences","volume":"111","author":"Gold","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-5215.2003.00029.x","article-title":"Atypical depression spectrum disorder \u2013 neurobiology and treatment","volume":"15","author":"Murck","year":"2003","journal-title":"Acta Neuropsychiatr"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.12.020","article-title":"Linking atypical depression and insulin resistance-related disorders via low-grade chronic inflammation: Integrating the phenotypic, molecular and neuroanatomical dimensions","volume":"93","author":"Sen","year":"2021","journal-title":"Brain Behav Immun"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3109\/08039488.2011.611894","article-title":"Role of cytokines in atypical depression","volume":"66","author":"Yoon","year":"2012","journal-title":"Nord J Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.01.009","article-title":"Defining the boundaries of atypical depression: Evidence from the HPA axis supports course of illness distinctions","volume":"86","author":"Stewart","year":"2005","journal-title":"J Affect Disord"},{"key":"B64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jad.2017.09.052","article-title":"Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review","volume":"233","author":"Juruena","year":"2018","journal-title":"J Affect Disord"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2012.03.009","article-title":"A review of atypical depression in relation to the course of depression and changes in HPA axis organization","volume":"37","author":"O\u2019Keane","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/s0006-3223(03)00692-9","article-title":"Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse","volume":"55","author":"Newport","year":"2004","journal-title":"Biol Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.01.146","article-title":"Cortisol levels in chronic fatigue syndrome and atypical depression measured using hair and saliva specimens","volume":"267","author":"Herane-Vives","year":"2020","journal-title":"J Affect Disord"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: Updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/da.22098","article-title":"Atypical depressive symptoms and obesity in a national sample of older adults with major depressive disorder","volume":"30","author":"Chou","year":"2013","journal-title":"Depress Anxiety"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07394","article-title":"Obesity comorbidity in unipolar major depressive disorder: refining the core phenotype","volume":"73","author":"Levitan","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jad.2015.06.020","article-title":"Atypical features in depression: Association with obesity and bipolar disorder","volume":"185","author":"\u0141ojko","year":"2015","journal-title":"J Affect Disord"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutos.2023.05.004","article-title":"Characteristics of blood biomarkers and eating behavior among older community-dwelling adults with typical and atypical depression","volume":"49","author":"Takeuchi","year":"2023","journal-title":"Clin Nutr Open Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.123","article-title":"Role of adiposity-driven inflammation in depressive morbidity","volume":"42","author":"Capuron","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B74","first-page":"266","article-title":"Atypical depression is associated with metabolic syndrome: a systematic review","volume":"50","author":"Ferriani","year":"2022","journal-title":"Actas Esp Psiquiatr"},{"key":"B75","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cca.2019.06.019","article-title":"Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes","volume":"496","author":"Reddy","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.04.011","article-title":"Glucocorticoids, cytokines and brain abnormalities in depression","volume":"35","author":"Zunszain","year":"2011","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.144","article-title":"Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression","volume":"18","author":"Lamers","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"101166","DOI":"10.1016\/j.lanepe.2024.101166","article-title":"Immuno-metabolic depression: from concept to implementation","volume":"48","author":"Penninx","year":"2025","journal-title":"Lancet Reg Health \u2013 Eur"},{"key":"B79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1037\/bul0000351","article-title":"Psychological stress during childhood and adolescence and its association with inflammation across the lifespan: A critical review and meta-analysis","volume":"148","author":"Chiang","year":"2022","journal-title":"Psychol Bull"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15370","article-title":"Childhood trauma, the stress response and metabolic syndrome: A focus on DNA methylation","volume":"55","author":"Womersley","year":"2022","journal-title":"Eur J Neurosci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1113\/JP285927","article-title":"Early adversity and the comorbidity between metabolic disease and psychopathology","volume":"604","author":"G\u00f3mez\u2010Ilescas","year":"2025","journal-title":"J Physiol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.70123","article-title":"Manifestation and measurement of atypical depression: A scoping review","volume":"32","author":"Zahra","year":"2025","journal-title":"Clin Psychol Psychother"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2019.12.017","article-title":"Depression subtypes, binge eating, and weight loss in bariatric surgery candidates","volume":"16","author":"Smith","year":"2020","journal-title":"Surg Obes Relat Dis Off J Am Soc Bariatr Surg"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.10.023","article-title":"Leptin dysregulation is specifically associated with major depression with atypical features: Evidence for a mechanism connecting obesity and depression","volume":"81","author":"Milaneschi","year":"2017","journal-title":"Biol Psychiatry"},{"key":"B85","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(20)30059-3","article-title":"Eating disorders","volume":"395","author":"Treasure","year":"2020","journal-title":"Lancet"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2009.100","article-title":"Atypical depression: Useful concept, but it\u2019s time to revise the DSM-IV criteria","volume":"34","author":"Thase","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4088\/jcp.0307e08","article-title":"Atypical depression: a valid subtype","author":"Parker","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.1.70","article-title":"Partial validation of the atypical features subtype of major depressive disorder","volume":"59","author":"Posternak","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-002-0395-0","article-title":"Can only reversed vegetative symptoms define atypical depression","volume":"252","author":"Benazzi","year":"2002","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/mpr.19","article-title":"Testing atypical depression definitions","volume":"14","author":"Benazzi","year":"2005","journal-title":"Int J Methods Psychiatr Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800260024003","article-title":"An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology","volume":"45","author":"Davidson","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"B92","first-page":"17","article-title":"Clinical significance of reversed vegetative subtypes of recurrent major depression","volume":"27","author":"Thase","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00014-2","article-title":"Pharmacotherapy response and diagnostic validity in atypical depression","volume":"54","author":"Sotsky","year":"1999","journal-title":"J Affect Disord"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and treatment of bipolar disorder: A review","volume":"330","author":"Nierenberg","year":"2023","journal-title":"JAMA"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2026.01.003","article-title":"Atypical depression is associated with a distinct clinical, neurobiological, treatment response and polygenic risk profile","volume":"100","author":"Shin","year":"2026","journal-title":"Biol Psychiatry"},{"key":"B97","volume-title":"Trattato Italiano Di Psichiatria","author":"Cassano","year":"1999"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3928\/00485713-20141208-04","article-title":"Atypical depression: History and future","volume":"44","author":"Stewart","year":"2014","journal-title":"Psychiatr Ann"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/bf02191157","article-title":"Atypical depression as a bipolar spectrum disease: Evidence from a longitudinal study: The early course of atypical depression","volume":"5","author":"Ebert","year":"1993","journal-title":"Psychiatr Danub"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1159\/000100004","article-title":"Types of depression more frequent in bipolar than in unipolar affective illness: results of the Polish DEP-BI study","volume":"40","author":"Rybakowski","year":"2007","journal-title":"Psychopathology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(83)90004-6","article-title":"Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors","volume":"5","author":"Akiskal","year":"1983","journal-title":"J Affect Disord"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s004060050067","article-title":"Prevalence of bipolar II disorder in atypical depression","volume":"249","author":"Benazzi","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/BF02191157","article-title":"The early course of atypical depression","volume":"241","author":"Ebert","year":"1991","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/s0193-953x(05)70093-9","article-title":"The evolving bipolar spectrum. Prototypes I, II, III, and IV","volume":"22","author":"Akiskal","year":"1999","journal-title":"Psychiatr Clin North Am"},{"key":"B105","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0193-953x(18)30935-3","article-title":"Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the \u201cborderline\u201d realm","volume":"4","author":"Akiskal","year":"1981","journal-title":"Psychiatr Clin North Am"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(01)00436-0","article-title":"Do patients with borderline personality disorder belong to the bipolar spectrum","volume":"67","author":"Deltito","year":"2001","journal-title":"J Affect Disord"},{"key":"B107","article-title":"The prevalence of cyclothymia in borderline personality disorder","volume":"51","author":"Levitt","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"B108","article-title":"Characterizing depression in borderline patients","volume":"48","author":"Soloff","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"B109","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-1314-5_3","article-title":"Borderline personality disorder, atypical depression, and cyclothymia: Diagnostic distinctions crossing mood and personality disorders borders","volume-title":"Borderline Personality and Mood Disorders: Comorbidity and Controversy","author":"Choi-Kain","year":"2015"},{"key":"B110","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0165-0327(02)00329-4","article-title":"The role of cyclothymia in atypical depression: toward a data-based reconceptualization of the borderline\u2013bipolar II connection","volume":"73","author":"Perugi","year":"2003","journal-title":"J Affect Disord"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2013.11.021","article-title":"Comorbid atypical depression in borderline personality disorder is common and correlated with anxiety-related psychopathology","volume":"55","author":"Gremaud-Heitz","year":"2014","journal-title":"Compr Psychiatry"},{"key":"B112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/j.2051-5545.2011.tb00013.x","article-title":"Are atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis","volume":"10","author":"Perugi","year":"2011","journal-title":"World Psychiatry"},{"key":"B113","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archpsyc.1993.01820130019004","article-title":"Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression","volume":"50","author":"Faedda","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(90)90065-D","article-title":"Is seasonal affective disorder a variant of atypical depression? Differential response to light therapy","volume":"33","author":"Stewart","year":"1990","journal-title":"Psychiatry Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0165-1781(99)00017-7","article-title":"Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects","volume":"86","author":"Schwartz","year":"1999","journal-title":"Psychiatry Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3109\/08039489109101986","article-title":"Carbohydrates, serotonin, and atypical depression","volume":"45","author":"M\u00f8ller","year":"1991","journal-title":"Nord Psykiatr Tidsskr"},{"key":"B117","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0165-0327(97)01447-X","article-title":"Atypical depressive symptoms in seasonal and non-seasonal mood disorders","volume":"44","author":"Tam","year":"1997","journal-title":"J Affect Disord"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90123-H","article-title":"Seasonality in atypical depression","volume":"31","author":"Pande","year":"1992","journal-title":"Biol Psychiatry"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(91)90099-E","article-title":"Atypical depressive symptoms possibly predict responsiveness to phototherapy in seasonal affective disorder","volume":"23","author":"Nagayama","year":"1991","journal-title":"J Affect Disord"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1590\/s1516-44462007000500005","article-title":"Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome","author":"Juruena","year":"2007","journal-title":"Rev Bras Psiquiatr Sao Paulo Braz 1999"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290090035008","article-title":"Response to phenelzine and amitriptyline in subtypes of outpatient depression","volume":"39","author":"Paykel","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780220113013","article-title":"Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies","volume":"37","author":"Ravaris","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800260037004","article-title":"Antidepressant specificity in atypical depression","volume":"45","author":"Liebowitz","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.1.118","article-title":"A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression","volume":"150","author":"McGrath","year":"1993","journal-title":"Am J Psychiatry"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.3.306","article-title":"Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders","volume":"145","author":"Quitkin","year":"1988","journal-title":"Am J Psychiatry"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810220051006","article-title":"Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication","volume":"47","author":"Quitkin","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810280035005","article-title":"Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design","volume":"48","author":"Quitkin","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00313-X","article-title":"Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features","volume":"26","author":"Stewart","year":"2002","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.5.431","article-title":"Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial","volume":"56","author":"Jarrett","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00628-1","article-title":"Fluoxetine versus phenelzine in atypical depression","volume":"40","author":"Pande","year":"1996","journal-title":"Biol Psychiatry"},{"key":"B132","article-title":"Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression","volume":"25","author":"Parsons","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810090029005","article-title":"Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression","volume":"46","author":"Quitkin","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.04200030093015","article-title":"The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial","volume":"29","author":"Robinson","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1991.tb03196.x","article-title":"Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression","volume":"84","author":"Larsen","year":"1991","journal-title":"Acta Psychiatr Scand"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197209000-00009","article-title":"Treatment of previously intractable depressions with tranylcypromine and lithium","volume":"155","author":"Himmelhoch","year":"1972","journal-title":"J Nerv Ment Dis"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1990.tb05328.x","article-title":"Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium","volume":"360","author":"Dierick","year":"1990","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1984.tb01206.x","article-title":"Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial","volume":"70","author":"Larsen","year":"1984","journal-title":"Acta Psychiatr Scand"},{"key":"B139","article-title":"Treatment of atypical depression with moclobemide: a sequential double controlled study","volume":"9","author":"Schweitzer","year":"1989","journal-title":"Int J Clin Pharmacol Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(89)90072-4","article-title":"A sequential double-blind controlled study of moclobemide and diazepam in patients with atypical depression","volume":"16","author":"Tiller","year":"1989","journal-title":"J Affect Disord"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(85)90027-7","article-title":"Biochemical effects of L-deprenyl in atypical depressives","volume":"20","author":"Liebowitz","year":"1985","journal-title":"Biol Psychiatry"},{"key":"B142","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/archpsyc.1984.01790190051006","article-title":"l-Deprenyl in atypical depressives","volume":"41","author":"Quitkin","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.1.31","article-title":"Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months\u2019 remission","volume":"154","author":"Stewart","year":"1997","journal-title":"Am J Psychiatry"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/da.20001","article-title":"Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline","volume":"19","author":"Joyce","year":"2004","journal-title":"Depress Anxiety"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(94)90015-9","article-title":"Moclobemide and fluoxetine in atypical depression: a double-blind trial","volume":"32","author":"Lonnqvist","year":"1994","journal-title":"J Affect Disord"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.3.344","article-title":"A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression","volume":"157","author":"McGrath","year":"2000","journal-title":"Am J Psychiatry"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850218","article-title":"Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: A single-blind, randomized clinical trial","volume":"23","author":"Taner","year":"2006","journal-title":"Adv Ther"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199100630-00007","article-title":"A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression","volume":"6","author":"Stratta","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1177\/026988119901300412","article-title":"A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression","volume":"13","author":"S\u00f6gaard","year":"1999","journal-title":"J Psychopharmacol (Oxf)"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v10n0305","article-title":"An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features","volume":"10","author":"Pae","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1201","article-title":"An open trial of venlafaxine for the treatment of late-life atypical depression","volume":"19","author":"Roose","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32830dd296","article-title":"Is duloxetine effective treatment for depression with atypical features","volume":"23","author":"Stewart","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/01.jcp.0000227700.263.75.39","article-title":"Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment","volume":"26","author":"Vaishnavi","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n1211","article-title":"Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features","volume":"69","author":"Trivedi","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.04.004","article-title":"Duloxetine-bupropion combination for treatment-resistant atypical depression: A double-blind, randomized, placebo-controlled trial","volume":"24","author":"Fornaro","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/acps.70127","article-title":"Patients with atypical symptoms of depression respond better to lithium augmentation than patients without atypical symptoms","author":"Buchbauer","year":"2026","journal-title":"Acta Psychiatr Scand"},{"key":"B157","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/acps.13216","article-title":"The effects of ketamine on typical and atypical depressive symptoms","volume":"142","author":"Park","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"B158","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.4088\/jcp.v69n0310","article-title":"The efficacy of acute electroconvulsive therapy in atypical depression","volume":"69","author":"Husain","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"B159","article-title":"A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression","volume":"53","author":"Mercier","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2010.01.010","article-title":"Treatment of atypical depression: Post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients","volume":"25","author":"Henkel","year":"2010","journal-title":"Eur Psychiatry"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/da.22580","article-title":"Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression","volume":"34","author":"Cuijpers","year":"2017","journal-title":"Depress Anxiety"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The antidepressant effects of GLP-1 receptor agonists: A systematic review and meta-analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.05.044","article-title":"A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology: Special section on \u201cTranslational and neuroscience studies in affective disorders\u201d. Section editor, Maria Nobile MD, PhD. This section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders","volume":"257","author":"Pozzi","year":"2019","journal-title":"J Affect Disord"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119509","article-title":"Association of glucagon-like peptide-1 receptor agonists and seven common mental disorders: A drug target and mediation Mendelian randomization","volume":"388","author":"Zhang","year":"2025","journal-title":"J Affect Disord"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70198","article-title":"Psychiatric effects of GLP-1 receptor agonists: A systematic review of emerging evidence","volume":"28","author":"Sa","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001032","article-title":"Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH\/NE states","volume":"7","author":"Gold","year":"2002","journal-title":"Mol Psychiatry"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852922000906","article-title":"The prescriber\u2019s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression","volume":"28","author":"Van Den Eynde","year":"2023","journal-title":"CNS Spectr"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1928447\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:19:22Z","timestamp":1790162362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1928447\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":167,"alternative-id":["10.3389\/fpsyt.2026.1928447"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1928447","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1928447"}}